116 related articles for article (PubMed ID: 29524555)
1. Elevated phospholipase D activity in androgen-insensitive prostate cancer cells promotes both survival and metastatic phenotypes.
Utter M; Chakraborty S; Goren L; Feuser L; Zhu YS; Foster DA
Cancer Lett; 2018 Jun; 423():28-35. PubMed ID: 29524555
[TBL] [Abstract][Full Text] [Related]
2. N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer.
Jennbacken K; Tesan T; Wang W; Gustavsson H; Damber JE; Welén K
Endocr Relat Cancer; 2010 Jun; 17(2):469-79. PubMed ID: 20233707
[TBL] [Abstract][Full Text] [Related]
3. Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells.
Uysal-Onganer P; Kawano Y; Caro M; Walker MM; Diez S; Darrington RS; Waxman J; Kypta RM
Mol Cancer; 2010 Mar; 9():55. PubMed ID: 20219091
[TBL] [Abstract][Full Text] [Related]
4. AT-101 (R-(-)-gossypol acetic acid) enhances the effectiveness of androgen deprivation therapy in the VCaP prostate cancer model.
McGregor N; Patel L; Craig M; Weidner S; Wang S; Pienta KJ
J Cell Biochem; 2010 Aug; 110(5):1187-94. PubMed ID: 20589722
[TBL] [Abstract][Full Text] [Related]
5. Phospholipase D couples survival and migration signals in stress response of human cancer cells.
Zheng Y; Rodrik V; Toschi A; Shi M; Hui L; Shen Y; Foster DA
J Biol Chem; 2006 Jun; 281(23):15862-8. PubMed ID: 16595654
[TBL] [Abstract][Full Text] [Related]
6. Development of an androgen-deprivation induced and androgen suppressed human prostate cancer cell line.
Lee SO; Dutt SS; Nadiminty N; Pinder E; Liao H; Gao AC
Prostate; 2007 Sep; 67(12):1293-300. PubMed ID: 17626246
[TBL] [Abstract][Full Text] [Related]
7. In vivo regulation of hTERT expression and telomerase activity by androgen.
Guo C; Armbruster BN; Price DT; Counter CM
J Urol; 2003 Aug; 170(2 Pt 1):615-8. PubMed ID: 12853842
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic herpesvirus HHV-8 promotes androgen-independent prostate cancer growth.
Mygatt JG; Singhal A; Sukumar G; Dalgard CL; Kaleeba JA
Cancer Res; 2013 Sep; 73(18):5695-708. PubMed ID: 24005834
[TBL] [Abstract][Full Text] [Related]
9. TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer.
Siu MK; Chen WY; Tsai HY; Chen HY; Yin JJ; Chen CL; Tsai YC; Liu YN
Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):172-178. PubMed ID: 28220803
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal analysis of androgen deprivation of prostate cancer cells identifies pathways to androgen independence.
D'Antonio JM; Ma C; Monzon FA; Pflug BR
Prostate; 2008 May; 68(7):698-714. PubMed ID: 18302219
[TBL] [Abstract][Full Text] [Related]
11. 14-3-3ζ, a novel androgen-responsive gene, is upregulated in prostate cancer and promotes prostate cancer cell proliferation and survival.
Murata T; Takayama K; Urano T; Fujimura T; Ashikari D; Obinata D; Horie-Inoue K; Takahashi S; Ouchi Y; Homma Y; Inoue S
Clin Cancer Res; 2012 Oct; 18(20):5617-27. PubMed ID: 22904106
[TBL] [Abstract][Full Text] [Related]
12. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.
Pandini G; Mineo R; Frasca F; Roberts CT; Marcelli M; Vigneri R; Belfiore A
Cancer Res; 2005 Mar; 65(5):1849-57. PubMed ID: 15753383
[TBL] [Abstract][Full Text] [Related]
13. Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells.
Nasu Y; Timme TL; Yang G; Bangma CH; Li L; Ren C; Park SH; DeLeon M; Wang J; Thompson TC
Nat Med; 1998 Sep; 4(9):1062-4. PubMed ID: 9734401
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
15. Perlecan, a candidate gene for the CAPB locus, regulates prostate cancer cell growth via the Sonic Hedgehog pathway.
Datta MW; Hernandez AM; Schlicht MJ; Kahler AJ; DeGueme AM; Dhir R; Shah RB; Farach-Carson C; Barrett A; Datta S
Mol Cancer; 2006 Mar; 5():9. PubMed ID: 16507112
[TBL] [Abstract][Full Text] [Related]
16. Androgens induce a distinct response of epithelial-mesenchymal transition factors in human prostate cancer cells.
Colditz J; Rupf B; Maiwald C; Baniahmad A
Mol Cell Biochem; 2016 Oct; 421(1-2):139-47. PubMed ID: 27562825
[TBL] [Abstract][Full Text] [Related]
17. CCAAT/Enhancer binding protein β controls androgen-deprivation-induced senescence in prostate cancer cells.
Barakat DJ; Zhang J; Barberi T; Denmeade SR; Friedman AD; Paz-Priel I
Oncogene; 2015 Nov; 34(48):5912-22. PubMed ID: 25772238
[TBL] [Abstract][Full Text] [Related]
18. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
Yang Q; Titus MA; Fung KM; Lin HK
J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
[TBL] [Abstract][Full Text] [Related]
19. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
Joseph IB; Nelson JB; Denmeade SR; Isaacs JT
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654
[TBL] [Abstract][Full Text] [Related]
20. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.
Seiler D; Zheng J; Liu G; Wang S; Yamashiro J; Reiter RE; Huang J; Zeng G
Prostate; 2013 Sep; 73(13):1378-90. PubMed ID: 23728788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
